Ann: Investor Presentation - $30m Capital Raise and FY22 Guidance, page-14

it's ironic with your user name and referencing intelligent investor, although I agree with you that most investment newsletters are probably not worth it.

I subscribed to a few when I was much younger and rarely did I find it a valuable resource. I always thought that if you were going to invest directly in the market then do your own research, but if you didn't have time to do your research then that was why you had unit trusts.
You are correct about the cost differential as a potential barrier, but the whole idea of opioids as a solution is nuts. it's one of the advantages penthrox has over the others IMO.